PROCF — Procaps SA Income Statement
0.000.00%
HealthcareHighly SpeculativeSmall Cap
- $163.60m
- $426.75m
- $409.92m
Annual income statement for Procaps SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 325 | 331 | 410 | 410 |
Cost of Revenue | ||||
Gross Profit | 182 | 191 | 236 | 240 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 287 | 268 | 339 | 370 |
Operating Profit | 37.4 | 63.1 | 70.5 | 40 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -9.98 | 0.849 | -87.2 | 52.7 |
Provision for Income Taxes | ||||
Net Income After Taxes | -17 | -10.4 | -101 | 42.5 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -17 | -10.4 | -101 | 42.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -17 | -10.4 | -101 | 42.5 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.151 | -0.093 | -0.894 | 0.306 |
Dividends per Share |